This study aimed to investigate the effects of long chain fatty acids (α-linolenic acid; 17 ALA, docosahexaenoic acid; DHA, eicosapentaenoic acid; EPA, linoleic acid; LA, 18 oleic acid; OA and palmitic acid; PA) at concentrations of 10-100 µM, on extended 19 bull sperm stored in vitro, for up to 7 days. Progressive linear motion (PLM), viability 20 (Experiments 1-3), ability to penetrate artificial mucus (Experiment 1), reactive 21 oxygen species (ROS; Experiment 2) and superoxide production (Experiment 3) were 22 assessed. Sperm maintained the ability to penetrate artificial mucus up to Day 4, 23 irrespective of treatment. In Experiments 2 and 3, DHA and EPA had detrimental 24 effects on PLM and viability. PA preserved PLM and viability at levels greater than 25 the control (P < 0.05), while sustaining ROS levels to a minimum, particularly on 26 Days 1 and 3 (P < 0.01) when ROS generation peaked in other treatments. In contrast, 27 superoxide production peaked on Day 0 (Experiment 3), and declined thereafter with 28 no significant effect of fatty acid. This study supports the notion that superoxide 29 dominates on Day 0, while its breakdown products from its reactions, hydrogen 30 peroxide and the hydroxyl radical as assessed by CM-H 2 DCFDA, contribute to ROS 31 generation on subsequent days. 32 33
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Introduction 37
Polyunsaturated fatty acids (PUFAs) have been widely reported, in both human and 38 animal models, to have beneficial effects on the cardiovascular (Bønaa et al., 1990 ) 39 and nervous (Alessandri et al., 2004; Brenna and Diau, 2007) systems. In more recent 40 years, there has been an increased focus on the role of PUFA's on female fertility 41 (Childs et al., 2008; Hammiche et al., 2010) and to a lesser extent, male fertility 42 (Wathes et al., 2007) . In the case of male fertility, the main focus of this work has 43 either been on the inclusion of specific fatty acids in the diet as reviewed by 44 (Comhaire and Mahmoud, 2003) and on the comparison of the lipid profile of sperm 45 between fertile and infertile males (Aksoy et al., 2006; Safarinejad et al., 2010) . 46 47 Supplementation with dietary fish oils, rich in long chain fatty acids, has been 48 demonstrated to successfully modify the fatty acid profile of the plasma and sperm 49 across a range of species (Kelso et al., 1997a; Comhaire et al., 2000; Rooke et al., 50 2001; Castellano et al., 2010; Gholami et al., 2010) , however, it is still unclear if this 51 has a beneficial effect on sperm cell function. An increase in the proportion of n-3 52 fatty acids in ejaculated boar sperm led to the number of progressively motile cells 53 being increased after being fed with tuna oil (Rooke et al., 2001) , however, others 54 found no beneficial effects in terms of semen production (Castellano et al., 2010) , the 55 lifespan of extended sperm stored at 17 o C or following cryopreservation (de Graaf et 56 al., 2007; Castellano et al., 2010) . Furthermore, supplementation of n-3, 57 docosahexaenoic acid in the diet was found to improve motility, velocity and the 58 viability of extended Holstein bull sperm, while it had no effect on frozen sperm 59 (Gholami et al., 2010 The aim of this experiment was to examine the effect of the addition of exogenous 141 fatty acids to extended bull sperm on the mitochondrial generation of the superoxide 142 anion. Semen was diluted in a citrate based diluent and stored in the presence of the 143 same fatty acid treatments as Experiment 2. All treatments were assessed on Days 0, 144 1, 3 and 7 for PLM, viability and generation of superoxide. Viability and superoxide 145 anion were assessed using flow cytometry and the fluorescent probes SYTOX Green 146 (Invitrogen, S7020) and MitoSOX Red (Invitrogen, M36008), respectively. MitoSOX 147
Red is an intra-cellular stain which fluoresces red in the presence of the superoxide 148 anion (·O 2 -). Four replicates were completed. 149 150
Progressive Linear Motion and Viability 151
PLM was assessed for each treatment by placing a 5 µL sample on a pre-warmed slide 152 and assessing 100 live cells, on a scale from 0 to 100 (0 indicating no progressive 153 linear motion observed among the live cells, 100 indicating 100% of live cells were 154 moving in a progressive linear motion). In Experiment 1, sperm viability was 155 examined using a nigrosin-eosin stain (0.068 M water soluble nigrosin; 0.014 M water 156 soluble eosin; 0.116 M sodium citrate). A sample of sperm (50 µL) from each 157 treatment was added to nigrosin-eosin stain, in a 1:1 ratio. This was incubated at 37 158 °C for 30 sec following which a smear was prepared on a glass slide and allowed to 159 dry on a heated stage at 37 °C. Sperm were viewed under a phase contrast microscope 160 8 (40X) and an average of three counts were taken, where 100 sperm were assessed in 161 each count. 162 163
Mucus Penetration Test 164
The mucus penetration test was performed as per Al Naib et al. (2011a) A representative sample from each treatment (100 µL) was added to 10 mL of filtered 182 PBS (pH 7.4) followed by centrifugation at 800 g for 10 min at 32 °C. Following 183 removal of the supernatant, sperm concentration of the pellet was assessed using a 184 haemocytometer, and the sample was diluted to 1.2 × 10 6 sperm/mL in pre-warmed 185 9 PBS (367 µL). CM-H 2 DCFDA (50 µL) was added to give a final working 186 concentration of 100 µM and samples were incubated for 30 min in a dry oven at 37 187 °C. PI (83 µL) was added to each of the samples to give a final working concentration 188 of 50 µM and samples were incubated for a further 15 min. Samples were 189 subsequently washed in 5 mL PBS by centrifugation at 800 g for 10 min at 32 °C. 
Statistical Analysis 217
All analyses were carried out using the SAS v9.1.3 software package (SAS Institute, 218
Cary, NC, USA) (SAS/STAT. 2000). Diagnostic tests were used to determine if data 219 had a normal distribution and data that did not approach a normal distribution were 220 transformed using a box-cox transformation (Box and Cox, 1964) in order to meet the 221 assumptions of analysis of variance. 222
223
Data presented in this paper shows the non-transformed values of the data, however, 224 all P-values were calculated using the transformed data where required. Data were 225 analysed using a repeated measures model for day that included the fixed effects of 226 day, fatty acid, concentration of fatty acid, all two way interactions, and the three-way 227 interaction of the fixed effects, where appropriate. Effects with a P-value <0.25 were 228 retained in the model. Repeated measures for day were fitted using the appropriate 229 
Experiment 2 256
PLM decreased over time in all treatments (P < 0.01), but the most dramatic decline 257 was in the EPA and DHA treatments with PLM declining more rapidly in the 100 µM 258 compared to the 10 µM treatments in both cases up to Day 3 (P < 0.05). PLM in the 259 12 respectively. PA (100 µM) and OA (10 and 100 µM) maintained the highest PLM up 261 to and including Day 7 (45.0 ± 6.39%; 27.0 ± 6.39% and 24.0 ± 6.39%, respectively) 262 in comparison to the control, which contained no progressively motile sperm on Day 263 7 (P < 0.01). 264
265
Similarly to PLM, viability declined over time (P < 0.05; except 10 µM OA). The 266 proportion of viable sperm ranged from 67.0 ± 6.05% to 36.7 ± 6.05% (100 µM OA 267 and 100 µM EPA, respectively) on Day 0 and from 45.6 ± 6.97% to 4.08 ± 6.97% 268 (100 µM PA and 100 µM DHA, respectively) on Day 7. The most rapid decline was 269 in both the 10 and 100 µM EPA and DHA treatments. In the 100 µM EPA treatment 270 viability decreased from 36.7 ± 6.05% on Day 0 to 26.7 ± 6.05 on Day 1 (P < 0.01) 271 while in the 100 µM DHA treatment on Day 0 and 1, viability decreased from 49.0 ± 272 6.05% to 28.0 ± 6.05%, respectively (P < 0.05). Interestingly, even though 100 µM 273 EPA and DHA treatments had the lowest number of viable sperm on Days 1, 3 and 7 274 (100 µM EPA: 27.6 ± 6.05%; 14.0 ± 6.05% and 4.6 ± 6.97%, 100 µM DHA: 28.0 ± 275 6.05%; 15.0 ± 6.05% and 4.1 ± 6.97%, respectively), both fatty acids at 10 µM 276 maintained a higher sperm cell viability compared to their 100 µM counterparts on all 277
Days (DHA; P < 0.01, EPA; P < 0.05). Consistent with the PLM test, OA (10 and 100 278 µM), ALA (10 µM) and PA had the greatest ability to maintain viability, with a score 279 for each on Day 7 of 45.6 ± 6.97%, 39.1 ± 6.97%, 44.6 ± 6.97% and 45.6 ± 6.97 %, 280 respectively. The control had a viability score of 64.0 ± 6.05% and 20.0 ± 6.97% on 281
Day 0 and 7, respectively. These results suggest that DHA and EPA (100 µM in both 282 fatty acids) are cytotoxic to sperm cells. 283
13
There was an effect of Day on ROS production (P < 0.0001) where ROS generation 285 peaked on either Day 1 or Day 3 dependent on treatment (Figure 2 ). The number of 286 live sperm positive for ROS was highest in the 100 µM LA, 10 µM EPA and 100 µM 287 OA treatments on Day 1 (68.6 ± 10.04%; 69.4 ± 10.04% and 67.9 ± 10.04%, 288 respectively) and in the 10 µM OA, 100 µM OA and 10 µM ALA treatments on Day 289 3 (76.9 ± 10.04%; 73.9 ± 10.04% and 73.3 ± 10.04%, respectively; Figure 2 ). The 290 level of ROS in the control treatment reached a peak of 67.5 ± 10.04% on Day 1 and 291 declined thereafter. PA displayed an inherent ability to maintain levels of ROS in 292 viable sperm to a minimum compared to the control on Days 1 and 3 (P < 0.01). On 293 Day 1, most treatments showed a lower level of ROS compared to the control (67.5 ± 294 10.04%), as only 100 µM LA, 10 µM EPA and 100 µM OA were higher (68.6 ± 295 10.04%; 69.4 ± 10.04% and 67.9 ± 10.04%, respectively). On Day 7 ROS generation 296 from live sperm was highest in the 10 µM LA (68.8 ± 11.63%, P < 0.05) and ALA 297 (59.7 ± 11.63%, P < 0.05) and 10 and 100 µM OA (68.2 ± 11.63% and 43.6 ± 298 11.63%, respectively) compared to the control (12.0 ± 11.63%). 299 300
Experiment 3 301
PLM decreased with time in all treatments (P < 0.01), but similar to Experiment 2 the 302 most dramatic decline in PLM was in the EPA and DHA treatments (10 and 100 µM 303 in both) which had lower PLM scores on Day 7 compared to the control (3.8 ± 304
11.27%; 6.4 ± 13.10%; 0.0 ± 17.46%, Control: 13.2 ± 13.10%). PA maintained the 305 highest PLM score up to Day 3 (78.8 ± 10.23%), but declined on Day 7. ALA (100 306 µM) and OA (both 10 and 100 µM) had the highest PLM on Day 7. There was a 307 significant effect of day on sperm cell viability; where viability declined in all 308 treatments over the course of seven days (P < 0.01). The proportion of viable sperm 309 14 ranged from 67.5 ± 4.51% to 53.5 ± 4.51% (control and 10 µM ALA, respectively) on 310 Day 0 and from 30.8 ± 4.51% to 5.3 ± 4.51% (10 µM ALA and 100 µM DHA, 311 respectively) on Day 7. PA had the highest number of live sperm on Day 7 (34.5 ± 312 4.51%) in comparison to all the other treatments including the control. Consistent 313 with Experiment 2, 100 µM EPA and DHA had a significantly lower number of live 314 sperm on Day 7 compared to the control (16.6 ± 4.87%, 5.3 ± 4.51% and 26.8 ± 315
4.51%, respectively; P < 0.05). 316
317
There was an effect of day on superoxide production (P < 0.0001) where the 318 production of superoxide peaked on Day 0 (except 10 µM EPA) with all treatments 319 having in excess of 72.7 ± 9.55% live sperm staining positive for superoxide (Figure  320 3). Superoxide levels remained greater than 59.7 ± 9.55% (value of 10 µM ALA) in 321 all treatments of Day 1 and declined thereafter, however, the rate of decline was not 322 dependent on treatment. Superoxide production in the 100 µM DHA treatment 323 remained high on Day 3 (59.6 ± 10.80%) compared to the other fatty acid treatments 324 and the control (54.3 ± 9.55%). 325 326
Discussion 327
This is the first published study which has evaluated the effect of the in vitro addition 328 of exogenous fatty acids on artificial mucus penetration and oxidative stress in 329 extended bull sperm. The main findings were that while PLM and viability decreased 330 with duration of storage, sperm cells maintained their ability to penetrate artificial 331 mucus up to and including Day 4 (Experiment 1). ROS generation peaked on Days 1 332 to 3 (Experiment 2) and declined thereafter, with OA and ALA showing a delay in the 333 peak of ROS production, while PA maintained ROS levels at basal levels over all 334 15 days in comparison to the control. DHA and EPA proved to be detrimental to both 335 PLM and viability (Experiment 2). While there was no significant effect of fatty acid 336 on superoxide production (Experiment 3), interestingly its production peaked on Day 337 0 and declined afterwards. 338 339 While PLM and viability did decrease significantly with incubation time (Experiment 340 1), there was no effect of time on the ability of sperm to penetrate artificial mucus, up 341 to and including Day 4. This is in contrast to a recent study that demonstrated that 342 after 2 days in storage, the ability of sperm cells to penetrate artificial mucus was 343 significantly decreased (Al Naib et al., 2011b) . In addition, there was no effect of 344 fatty acid on the ability of sperm to penetrate artificial mucus in comparison to the 345 control. It is postulated that the lack of effect could be attributed to the egg yolk based 346 diluent used in Experiment 1 given the high proportion of lipids in egg yolk 347 potentially interacting with the sperm membrane. other PUFAs, such as arachidonic acid (Lukiw and Bazan, 2008; Oborna et al., 2010) 361 and the in vitro addition of highly unsaturated fatty acids, like DHA, increases the 362 amount of ROS formed by human sperm (Aitken and Baker, 2006) . In the current 363 study, EPA had similar effects on PLM and viability as DHA. It was noted however, 364 that 10 µM EPA was not as detrimental as 10 µM DHA on PLM and viability. To the 365 best of our knowledge this the first report of the effects of EPA on bull sperm in vitro. 366
367
In general, ALA, OA and PA maintained PLM and viability up to and including Day 368 7 (Experiment 2). In the ALA and OA treatments ROS generation peaked on Day 3, 369 compared to Day 1 in the control. Interestingly, PA maintained ROS at the lowest 370 levels on all days, corresponding to its good viability and PLM scores (as well as 371 rapid movement; data not shown). PA is the most prominent saturated fatty acid in 372 bull and human sperm fractions (Kelso et al., 1997b; Lenzi et al., 2000) , while OA 373 has a high representation in both these models. Neill and Masters (1971) demonstrated 374 that fatty acids added in vitro, are incorporated into the membrane of the sperm cell. 375
Thus, it is likely that the incorporation of PA (no double bonds) or OA (one double 376 bond) into the sperm membrane would reduce the cells susceptibility to attack by 377 ROS. Our findings are supported by Aitken et al. (2006) who demonstrated that short 378 term exposure of human sperm to PA had no effect on ROS generation. 379 380 Poor quality human spermatozoa have been demonstrated to have higher levels of 381 unsaturated fatty acids than normal sperm cells (Ollero et al., 2001) and Cocco et al. 382 (1999) suggested that these PUFAs could inhibit specific complexes of the 383 mitochondrial electron transport carrier system, consequently causing the leakage of 384 electrons, followed by superoxide formation. It is for this reason that excessive 385 generation of superoxide is a key indicator of poor, defective sperm (De Iuliis et al., 386 2006) and has been reported to be one of the principal ROS generated by sperm cells 387 (Lenzi et al., 1996) (all n-3), LA (n-6) or OA (n-9) at concentrations of 10 and 100 µM assessed on Days 575 0, 1, 3 and 7. Both a saturated fat control (PA) and a vehicle control were included; 576 vertical bars represent s.e.m (n = 4 replicates) 577
